News Center

While the whole nation was celebrating the birthday of China, the 2025 Russian Diagnostic Summit (RDS) was grandly held in Moscow from October 1st to 3rd. As one of the largest, most professional and most influential medical industry events in Russia and even the Commonwealth of Independent States (CIS), RDS witnessed Lifotronic making a heavyweight appearance with its latest series of in vitro diagnostic (IVD) total solution products. The company engaged in in-depth discussions on the technological development of "Made in China" with partners and peers from Russia and neighboring countries.



Electro-Chemiluminescence lmmunoassay(ECLIA) Analyzers：

As the first manufacturer of Electro-Chemiluminescence lmmunoassay products in China and the second globally, Lifotronic has successively launched a series of fully automated electro-chemiluminescence immunoassay analyzers such as eCL8000, eCL9000, and eCL8600, along with over 100 reagent items. These offerings provide advanced immunoassay solutions for medical institutions and laboratories in more than 120 countries worldwide.
During this exhibition, Lifotronic specially showcased the high-throughput fully automated electro-chemiluminescence immunoassay analyzer eCL9000. The analyzer achieves a constant testing speed of 300 tests per hour (T/H) for a single module, and when four units are connected in parallel, the testing speed reaches 1200 T/H. Notably, it enables rapid detection within 9 minutes for items related to inflammation, acute abdomen, cardiovascular diseases, etc., helping gain precious golden rescue time for patients and meeting the needs of clinical emergency testing. The eCL9000 has been successfully installed in numerous large-scale hospitals and laboratories in Russia. With its accurate and efficient testing performance, it provides reliable data support for clinical diagnosis, contributes to the improvement of local diagnosis and treatment efficiency as well as medical service quality, and serves as a crucial tool for Lifotronic's continuous development in the high-end immunodiagnostic market in Russia.



High-Performance Liquid Chromatography (HPLC) Analyzers (Glycated Hemoglobin Analysis):
Through independent innovation and iterative upgrades, Lifotronic has continuously launched a series of hemoglobin analyzers based on high-performance liquid chromatography (HPLC), including models H100Plus, H100, H9, H8, and GH-900Plus. These products cater to the needs of medical institutions and laboratories at all levels.
Among them, the H100Plus can achieve fast and accurate detection within 58 seconds. It eliminates abnormal interference by separating and identifying hemoglobin variants, ensuring more reliable results. Lifotronic's series of  hemoglobin analyzers boast superior performance. The mainstream models have reached international standards in terms of detection range, repeatability, and anti-interference capability, aligning with global benchmarks. They have obtained dual certifications from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the National Glycohemoglobin Standardization Program (NGSP), and have ranked first among Chinese brands in export volume for consecutive years. In the local Russian market, after nearly three years of joint efforts with partners, Lifotronic's hemoglobin analyzers have gained high recognition from end-users at all levels in Russia, and the installation volume of these products now ranks first in the Russian market.





The AC 630 auto hematology analyzer, also on display, received its Russian medical device registration certificate in February of this year, marking Lifotronic's official breakthrough in the Russian hematology market. This marks a key foundation for the company's subsequent full-line AC series market access and localized installation services, further solidifying the company's competitive advantage in Russian laboratory solutions. The AC 630 can run at speeds of up to 70 T/H and can test in three modes: venous whole blood, capillary whole blood, and prediluted blood. It also features intelligent sample mixing and automatic shutdown functions, and emergency units can accept cap-piercing sample tubes, meeting the needs of clinical emergency testing.



On October 1st, Lifotronic in collaboration with the Department of Clinical Laboratory Diagnostics, RMAPO, hosted a satellite symposium in Hall A with Professors Alexander Roytman and Alexey Bugrov, focusing on "Diabetes Mellitus and Metabolic Syndrome – a challenge of the 21st Century" The two experts will present on the topics of "Laboratory diagnostics of diabetes mellitus and metabolic syndrome in the context of clinical guidelines" and "Challenges and prospects of glycated hemoglobin determination in modern laboratory medicine" respectively, and engage in discussions with on-site medical laboratory experts and peers. Their sharing received warm applause and high recognition from the participants.








On the occasion of the China's National Day, Lifotronic, as a company committed to growing into a globally respected supplier of medical products and services, will steadily promote high-quality "Made in China" medical products and services to the Russian market and markets of countries along the "Belt and Road" in the future. It will contribute to the further improvement of medical testing standards, provide more accurate and efficient clinical testing solutions for hospitals and laboratories at all levels around the world, and create greater value for human health and lives.